UBS Group’s Insulet PODD Stock Holding History

UBS Group’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-82,600	Closed	-$7.85M	–	8086
2019 Q1	$7.85M	Buy	+82,600	New	+$7.08M	﹤0.01%	1848

Other funds holding PODD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

UBS Group's PODD Position: Q2 2026 in Review

UBS Group increased its Insulet (PODD) stake by 22% in Q2 2026, buying an estimated $16.2M and bringing the position to 543,030 shares worth $82.7M. The position accounts for 0.01% of the portfolio, ranked #1270.

UBS Group first reported a position in PODD in Q4 2014 and has held it in 47 quarters since. The position peaked at $93.6M in Q1 2026. 730 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

UBS Group held 543,030 shares of Insulet worth $82.7M as of Q2 2026.
UBS Group bought 97,091 Insulet shares in Q2 2026, an estimated $16.2M.
Insulet made up 0.01% of UBS Group's portfolio in Q2 2026, its #1270 holding.
UBS Group first reported a position in Insulet in Q4 2014 and has held it in 47 quarters since.
UBS Group's Insulet position peaked at $93.6M in Q1 2026.
730 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.